Author:
Joubert Jacques,Strydom Natasha,Geldenhuys Werner J.,Greyling Yolande,V. Dyk Sandra,Malan Sarel F.
Abstract
Introduction:
Recent research points to the Sigma Receptor (σR) as a possible neuromodulatory system with multi-functional action and σ1Rs have been suggested as a drug target for a number of CNS conditions. Hexacyclododecylamines have shown σ1R activity and provide an advantageous scaffold for drug design that can improve the blood-brain barrier permeability of privileged structures.
Methods and Materials:
A series of oxa- and aza- hexaxcyclododecylamines were synthesised and evaluated for sigma-1 receptor activity and voltage-gated calcium channel blocking ability to determine the effect of inclusion of amine containing heterocycles.
Results & Discussion:
The compounds had promising σ1R activities (Ki = 0.067 – 11.86 µM) with the aza-hexacyclododecylamines 12, 24 and 27 showing some of the highest affinities (Ki = 0.067 µM, 0.215 µM and 0.496 µM respectively). This confirms, as observed in previous studies, that the aza compounds are more favourable for σ1R binding than their oxa counterparts. The addition of the amine heterocycle showed affinities similar to that of related structures with only two lipophilic binding regions. This indicates that the inclusion of an amine heterocycle into these structures is a viable option in the design of new σ1R ligands. Significant voltage-gated calcium channel blocking ability was also observed for 12, 24 and 27, suggesting a link between σ1R activity and intracellular calcium levels.
Conclusion:
The σ1R activity and potential effect on other receptor classes and calcium channels could prove beneficial in pharmacological application.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference50 articles.
1. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE.
The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
J Pharmacol Exp Ther
1976;
197
(3)
: 517-32.
2. Quirion R, Chicheportiche R, Contreras P, et al.
Classification and nomenclature of phencyclidine and sigma receptor sites.
Trends Neurosci
1987;
10
: 444-6.
3. Hellewell SB, Bowen WD.
A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Brain Res
1990;
527
(2)
: 244-53.
4. Quirion W, Bowen Y, Itzhak J, et al.
A proposal for the classification of sigma binding sites.
Trends Pharmacol Sci
1992;
13
: 85-6.
5. Hanner F, Moebius A, Flandorfer H, Knaus J, Striessnig E Kempner, Glossmann H.
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
P Natl Acad Sci
1996;
93
: 8072-7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献